»‘Raising the Bar’ through Clinical Trials
»A Large Patient Population
»Getting Started…
»Clinical Trial Phases
»Major Successes

The Princess Margaret is fortunate to be located at the heart of a large cosmopolitan city, which makes it ideal for clinical trials. Dr. Mary Gospodarowicz, head of the Cancer Program for The Princess Margaret, says that in addition to being able to draw from a large population that is ethnically diverse, “The Princess Margaret has the internal breadth and depth to make it one of the most comprehensive cancer centres in the world.  There are very few cancer situations that we are not equipped to treat.”

The clinical trials at Princess Margaret are spread across many disease sites, and a large number of trials involve multiple disease sites.

Disease Site	Number of Open Trials
Breast	29
Gastrointestinal	34
Gynecological	29
Head & Neck	26
Leukemia	44
Lung	37
Lymphoma	24
Skin/Sarcoma	4
Urology	66
Central Nervous System	7
Endocrine	3
Multiple Disease Sites	56

Almost two-thirds of the clinical trials test new drug treatments and are run by the department of Medical Oncology, while just under 100 trials are run by the department of Radiation Oncology, and about 40 are run by the department of Surgical Oncology.